chevron_leftBack
As of 5 June 2026, NRGene Technologies Ltd. has a market cap of $11.84M USD, ranking #40362 globally and #536 in Israel.
It ranks #3594 in the Healthcare sector, and #705 in the Biotechnology industry.
Key Stats
Market Cap
$11.84MUSD
34.01M ILS
Enterprise Value
$6.24MUSD
18.03M ILS
Revenue (TTM)
$3.52MUSD
10.11M ILS
EBITDA (TTM)
-$1.63MUSD
-4.71M ILS
Net Income (TTM)
-$1.67MUSD
-4.79M ILS
EBITDA Margin
-47%
Profit Margin
-47%
PS Ratio
3.4
PB Ratio
2.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Gil Ronen
open_in_new
Employees
23
Founded
2009
Website
nrgene.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.1% | -1.1% | -6.1% | 9% | -13% | 1.2% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
NRGN
אנרג'ין טכנולוגיות בע''מ Ordinary Shares
ISIN: IL0011720716
Shares Out.:
Shares Outstanding:
13.324M1
Shares Float:
7.262M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
253 ILA |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About NRGene Technologies Ltd.
NRGene Technologies Ltd operates as a research and development company focusing on intellectual property-intensive technological products in the field of AgTech in North America, Europe, the Middle East, Africa, Asia Pacific, and internationally. It develops and commercializes plant varieties, traits, and animals based on artificial intelligence (AI) technology and software tools for analyzing genetic information. The company also offers Supree semi-dried cherry tomatoes; clubroot-resistant canola; and black soldier fly as an alternative to animal-based protein. Its technology portfolio includes DeNovoMAGIC, a de novo assembly solution that assembles genomes. NRGene Technologies Ltd was incorporated in 2009 and is based in Ness Ziona, Israel.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: KMDA
|
$470.55M
4K%
|
23.3
|
|
TLV: DNA
|
$335.01M
3K%
962.09M ILS
|
267.3
|
|
NASDAQ: CGEN
|
$245.84M
2K%
|
6.9
|
|
NASDAQ: ENLV
|
$190.26M
2K%
|
0.0
|
|
TLV: KDST
|
$56.08M
374%
161.06M ILS
|
-
|
|
NASDAQ: PLUR
|
$34.07M
188%
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
2M%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
1M%
|
19.0
|
|
EBR: ARGX
|
$48.01B
405K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.48B
376K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$43.01B
363K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.55B
359K%
33.71B CHF
|
37.2
|
chevron_leftBack